Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director · CEO and President | February 20, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date February 20, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,834 |
Ending reported balance
After 2026-02-20 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 9,005 · Balance 41,691 F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Row 2 · 2026-02-20 · Tax withholding · Disposed 4,010 · Balance 37,681 F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Row 3 · 2026-02-20 · Grant · Acquired 62,153 · Balance 99,834 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 63,658 |
Reported balance
Holding disclosure · report date 2026-02-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 63,658 F4: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.
F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.
F4: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 25, 2026 00:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 62,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019289 · tm267181-7_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,834 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 4,010 | $59.53 | $238,715.30 |
DisclosureSEC source: 0001104659-26-019289 · tm267181-7_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,681 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 9,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019289 · tm267181-7_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,691 F1 · shares: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 1,635 | $59.76 | $97,707.60 |
DisclosureSEC source: 0001104659-26-017052 · tm266746-6_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,686 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:20 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 968 | $66.33 | $64,207.44 |
DisclosureSEC source: 0001104659-26-013528 · tm266005-3_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,321 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. F2 · balance_after: Includes (i) 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2025 and (ii) 27 shares acquired under the Plan on December 31, 2025. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 8,273 | $186.45 | $1,542,500.85 |
DisclosureSEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,149 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 18,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,422 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 16,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,964 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 896 | $182.15 | $163,206.40 |
DisclosureSEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,935 F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherStock Option (Right to Buy) · Derivative | 2,915 | Not disclosed Strike: $227.53 | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 5,553 Underlying: Common Stock · 2,915 shares Expires 2030-12-14 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F5 · derivative.exercise_date: The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherStock Option (Right to Buy) · Derivative | 13,703 | Not disclosed Strike: $194.82 | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 26,100 Underlying: Common Stock · 13,703 shares Expires 2030-12-14 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F4 · derivative.exercise_date: The option is fully vested and exercisable. F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherStock Option (Right to Buy) · Derivative | 28,840 | Not disclosed Strike: $71.00 | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 54,934 Underlying: Common Stock · 28,840 shares Expires 2029-12-16 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F4 · derivative.exercise_date: The option is fully vested and exercisable. F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherStock Option (Right to Buy) · Derivative | 27,254 | Not disclosed Strike: $42.15 | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 51,913 Underlying: Common Stock · 27,254 shares Expires 2028-12-18 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F4 · derivative.exercise_date: The option is fully vested and exercisable. F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 61,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 117,658 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068246 · tm2416039-2_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO, President & Chairperson 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 112,731 F1 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 440 | $213.26 | $93,834.40 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 63,658 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 232 | $210.99 | $48,949.68 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 64,098 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,310 | $209.46 | $274,392.60 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 64,330 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,492 | $208.34 | $310,843.28 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 65,640 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,420 | $207.25 | $294,295.00 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 67,132 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,379 | $206.19 | $696,716.01 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 68,552 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,645 | $205.27 | $2,390,369.15 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 71,931 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 10,694 | $204.35 | $2,185,318.90 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 83,576 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 9,388 | $203.33 | $1,908,862.04 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 94,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 440 | $213.26 | $93,834.40 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 63,658 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 232 | $210.99 | $48,949.68 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 64,098 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,310 | $209.46 | $274,392.60 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 64,330 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,492 | $208.34 | $310,843.28 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 65,640 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,420 | $207.25 | $294,295.00 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 67,132 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,379 | $206.19 | $696,716.01 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 68,552 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 11,645 | $205.27 | $2,390,369.15 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 71,931 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 10,694 | $204.35 | $2,185,318.90 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 83,576 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 9,388 | $203.33 | $1,908,862.04 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 94,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:37 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 13,755 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022562 · tm245999-3_4seq1.xml · derivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,755 Underlying: Common Stock · 13,755 shares Expires 2034-02-09 F7 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:37 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 8,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022562 · tm245999-3_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,690 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,086 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 14 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 9,086 shares Expires 2027-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 113,698 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 13 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 113,698 shares Expires 2024-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 63,490 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 12 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 63,490 shares Expires 2028-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,762 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · derivative · entry 11 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 0 Underlying: Common Stock · 21,762 shares Expires 2028-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F1 · ownership.nature: Securities held by the TPH 2022 LLC. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 4,175 | $147.78 | $616,981.50 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 115,629 F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 52,411 | $148.02 | $7,757,876.22 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 119,804 F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 31,376 | $147.88 | $4,639,882.88 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 172,315 F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 10,758 | $147.88 | $1,590,893.04 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 117,655 F3 · kind: Reflects the payment of the relevant exercise price and tax liability incident to the exercise of options by the withholding of common stock. F1 · ownership.nature: Securities held by the TPH 2022 LLC. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 9,086 | $0.94 | $8,540.84 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 203,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 113,698 | $2.07 | $235,354.86 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 194,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 63,490 | $10.38 | $659,026.20 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 80,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 23:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 21,762 | $10.38 | $225,889.56 |
DisclosureSEC source: 0001104659-23-109451 · tm2328548-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 128,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleStock Option (Right to Buy) · Derivative | 2,499 | Not disclosed Strike: $227.53 | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 20 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 5,553 Underlying: Common Stock · 2,499 shares Expires 2030-12-14 F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F10 · derivative.exercise_date: The grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleStock Option (Right to Buy) · Derivative | 11,745 | Not disclosed Strike: $194.82 | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 19 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 26,100 Underlying: Common Stock · 11,745 shares Expires 2030-12-14 F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F9 · derivative.exercise_date: The grant of options to purchase 43,200 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 20:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleStock Option (Right to Buy) · Derivative | 24,720 | Not disclosed Strike: $71.00 | Not disclosed |
DisclosureSEC source: 0001104659-23-100460 · tm2326030-1_4seq1.xml · derivative · entry 18 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 54,934 Underlying: Common Stock · 24,720 shares Expires 2029-12-16 F4 · price: The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm. F8 · derivative.exercise_date: The original grant of options to purchase 65,000 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F3 · balance_after: On September 8, 2023, the TPH 2022 LLC sold 45% of its non-voting membership units. The total amount of securities reported remains unchanged because the Reporting Person continues to have a pecuniary interest in the securities held by the TPH 2022 LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.